Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system

Physics in Medicine and Biology

Volumn 50, Issue 5, 2005, Pages 947-958

  Lehmann, Joerg ^a,b   Siantar, Christine Hartmann ^a,b   Wessol, Daniel E ^c   Wemple, Charles A ^c   Nigg, David ^c   Cogliati, Josh ^d   Daly, Tom ^a   Descalle, Marie Anne ^a   Flickinger, Terry ^a   Pletcher, David ^a   DeNardo, Gerald ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IDAHO NATIONAL LABORATORY   (United States)

^d Montana State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL METHODS; DATA REDUCTION; DOSIMETRY; MONTE CARLO METHODS; NEUTRONS; PATIENT TREATMENT;

COMPUTATIONAL DOSIMETRY; MOLECULAR TARGETED RADIOTHERAPHY; NEUTRON RADIOTHERAPHY; PHOTON-ELECTRON THERAPY;

RADIOTHERAPY;

ACCURACY; BRACHYTHERAPY; COMMUNITY; COMPUTER INTERFACE; COMPUTER PROGRAM; CONFERENCE PAPER; DOSE CALCULATION; ELECTRON THERAPY; GEOMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MATHEMATICAL COMPUTING; MINERVA SYSTEM; MOLECULAR TARGETED RADIOTHERAPY; MONTE CARLO METHOD; NEUTRON CAPTURE THERAPY; PHOTON; PRIORITY JOURNAL; PROTON TRANSPORT; PUBLICATION; RADIOTHERAPY; SYSTEM ANALYSIS; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

BORON NEUTRON CAPTURE THERAPY; DATABASES; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MONTE CARLO METHOD; NEUTRONS; PHANTOMS, IMAGING; PHOTONS; RADIOMETRY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SOFTWARE; TISSUE DISTRIBUTION;

EID: 20144389821     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/50/5/017     Document Type: Conference Paper

References (30)

1. Benua R S, Cicale N R, Sonenberg M and Rawson R W 1962 The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer Am. J. Roentgenol. Radium. Ther. Nucl. Med. 87 171-82
2. Bodey R K, Flux G D and Evans P M 2003 Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose Cancer Biother. Radiopharm. 18 89-97
3. Bolch W E et al 1999 MIRD pamphlet no 17: the dosimetry of nonuniform activity distributions-radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee J. Nucl. Med. 40 11S-36S
4. Buffa F M, Verhaegen F, Flux G D and Dearnaley D P 2003 A Monte-Carlo method for interface dosimetry of beta emitters Cancer Biother. Radiopharm. 18 463-71
5. DeNardo G L, Raventos A, Hines H H, Scheibe P O, Macey D J, Hays M T and DeNardo S J 1985 Requirements for a treatment planning system for radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 11 335-48
6. DeNardo S J, Richman C M, Goldstein D S, Shen S, Salako Q, Kukis D L, Meares C F, Yuan A, Welborn J L and Denardo G L 1997 Yttrium-90/indium-111-DOTA- peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer Anticancer Res. 17 1735-44
7. DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C and DeNardo S 2003 Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs Cancer Biother. Radiopharm. 18 231-7
8. Descalle M A, Hartmann Siantar C L, Dauffy L, Nigg D W, Wemple C E, Yuan A and DeNardo G L 2003 Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy Cancer Biother. Radiopharm. 18 71-9
9. Flux G D, Guy M J, Beddows R, Pryor M and Flower M A 2002 Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy Phys. Med. Biol. 47 3211-23
10. Flux G D, Guy M J, Papavasileiou P, South C, Chittenden S J, Flower M A and Meller S T 2003 Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG Cancer Biother. Radiopharm. 18 81-7
11. Frandsen M W, Wessol D E, Wheeler F J and Starkey D 1998 8th International Symposium on Neutron Capture Therapy (New York, La Jolla, CA: Plenum)
12. Furhang E E, Chui C S, Kolbert K S, Larson S M and Sgouros G 1997 Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy Med. Phys. 24 1163-72
13. Furhang E E, Chui C S and Sgouros G 1996 A Monte Carlo approach to patient-specific dosimetry Med. Phys. 23 1523-9
14. Gosling J, Joy B and Steele G 1996 The Java Language Specification (Reading, MA: Addison-Wesley)
15. Hartmann Siantar C L et al 2001 Description and dosimetric verification of the PEREGRINE Monte Carlo dose calculation system for photon beams incident on a water phantom Med. Phys. 28 1322-37
16. Hartmann Siantar C L, Vetter K, DeNardo G L and DeNardo S J 2002 Treatment planning for molecular targeted radionuclide therapy Cancer Biother. Radiopharm. 17 267-80
17. Johnson T K, McClure D and McCourt S 1999 MABDOSE. II: validation of a general purpose dose estimation code Med. Phys. 26 1396-403
18. Johnson T K and Vessella R L 1989 On the possibility of 'real-time' Monte Carlo calculations for the estimation of absorbed dose in radioimmunotherapy Comput. Methods Programs Biomed. 29 205-10
19. Lehmann J et al 2004 Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system Current Topics in Monte Carlo Treatment Planning, Advanced Workshop (McGill University, Montreal May 3-5, 2004) oral presentation
20. Nigg D W 2003 Computational dosimetry and treatment planning considerations for neutron capture therapy J. Neurooncol. 62 75-86
21. Nigg D W, Wheeler F J, Wessol D E, Capala J and Chadha M 1997 Computational dosimetry and treatment planning for boron neutron capture therapy J. Neurooncol. 33 93-104
22. Rubin P 1989 Law and order of radiation sensitivity. Absolute versus relative Front. Radiat. Ther. Oncol. 23 7-40
23. Siegel J A et al 1999 MIRD pamphlet no 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates J. Nucl. Med. 40 37S-61S
24. Snyder W S, Ford MR, Warner G G and Watson S B 1978 Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom Revised MIRD Pamphlet no 5 (Society of Nuclear Medicine)
25. Stabin M G 1999 Internal dosimetry in the use of radiopharmaceuticals in therapy-science at a crossroads? Cancer Biother. Radiopharm. 14 81-9
26. Thomas S R 2002 Options for radionuclide therapy: from fixed activity to patient-specific treatment planning Cancer Biother. Radiopharm. 17 71-82
27. Wahl R L 2003 The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab Semin. Oncol. 30 31-8
28. Wemple C A et al 2004 MINERVA-a multi-modal radiation treatment planning system Appl. Radiat. Isot. 61 745-52
29. Williams L E 1995 Estimation of absorbed doses in radioimmunotherapy Med. Phys. 22 958
30. Zelenetz A D 2003 A clinical and scientific overview of tositumomab and iodine I 131 tositumomab Semin. Oncol. 30 22-30